Dechra Pharmaceuticals Plc (DPH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2008 | 06-2007 | 06-2006 | 06-2005 | 06-2004 | |
| Sales | 304,371 | 253,803 | 232,471 | 210,267 | 186,843 |
| Cost of Goods | 250,771 | 216,952 | 199,205 | 180,550 | 161,422 |
| Gross Profit | 53,600 | 36,851 | 33,266 | 29,717 | 25,421 |
| Operating Expenses | 37,341 | 23,009 | 20,977 | 18,504 | 16,233 |
| Operating Income | 16,259 | 13,842 | 12,289 | 11,213 | 9,188 |
| Interest Expense | 4,204 | 2,228 | 1,977 | 1,909 | 1,708 |
| Other Income | -350 | 1,005 | 732 | 397 | -111 |
| Pre-tax Income | 11,705 | 12,619 | 11,044 | 9,701 | 7,369 |
| Income Tax | 3,387 | 3,772 | 3,487 | 2,674 | 2,288 |
| Net Income Continuous | 8,318 | 8,847 | 7,557 | 7,027 | 5,081 |
| Net Income | $8,318 | $8,847 | $7,557 | $7,027 | $5,081 |
| EPS Basic Total Ops | 0.13 | 0.15 | 0.13 | 0.13 | 0.09 |
| EPS Basic Continuous Ops | 0.13 | 0.15 | 0.13 | 0.13 | 0.09 |
| EPS Diluted Total Ops | 0.13 | 0.15 | 0.13 | 0.12 | 0.09 |
| EPS Diluted Continuous Ops | 0.13 | 0.15 | 0.13 | 0.12 | 0.09 |
| EBITDA(a) | $20,430 | $15,968 | $14,043 | $12,586 | $10,065 |